- Details
- Description
-
Packaging Size4t/box
-
Strength5mg
-
CompositonEntinostat
-
TreatmentHR+, HER2-, locally advanced or metastatic breast cancer
-
FormTablet
-
Brand景助达
-
Quantity Unit5mg*4t/box
-
ManufacturerEOC Pharma.,China
Entinostat is a synthetic drug that inhibits histone deacetylase (HDAC) enzymes.
- Entinostat sold as brand name 景助达® in china.
On April 30, 2024, Entinostat was approved in China for use in combination with an aromatase inhibitor for the treatment of patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2-negative (HER2-) locally advanced or metastatic breast cancer that has recurred or progressed after endocrine therapy.